$163 Million is the total value of Tamarack Advisers, LP's 33 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 82.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDRX | Buy | ALLSCRIPTS HEALTHCARE SOLUTIequity | $20,989,000 | +31.6% | 1,475,000 | +18.0% | 12.85% | +38.0% |
| Sell | NOVOCURE LTDequity | $14,760,000 | -5.7% | 743,554 | -17.8% | 9.04% | -1.1% | |
| NKTR | Sell | NEKTAR THERAPEUTICSequity | $13,200,000 | +14.4% | 550,000 | -6.8% | 8.08% | +20.0% |
| MDT | Buy | MEDTRONIC PLCequity | $12,832,000 | +221.3% | 165,000 | +266.7% | 7.86% | +237.1% |
| CORI | Sell | CORIUM INTERNATIONAL INCequity | $10,526,000 | +44.7% | 950,000 | -2.6% | 6.44% | +51.8% |
| GILD | Sell | GILEAD SCIENCES INCequity | $10,128,000 | +6.0% | 125,000 | -7.4% | 6.20% | +11.2% |
| PCRX | Buy | PACIRA PHARMACEUTICALS INCequity | $9,388,000 | -8.5% | 250,000 | +16.3% | 5.75% | -4.0% |
| LH | Sell | LABORATORY CRP OF AMER HLDGSequity | $9,058,000 | -13.6% | 60,000 | -11.8% | 5.55% | -9.4% |
| NUVA | New | NUVASIVE INCequity | $8,874,000 | – | 160,000 | +100.0% | 5.43% | – |
| SRCL | Buy | STERICYCLE INCequity | $8,809,000 | +92.4% | 123,000 | +105.0% | 5.39% | +101.8% |
| QDEL | New | QUIDEL CORPequity | $6,579,000 | – | 150,000 | +100.0% | 4.03% | – |
| STE | Sell | STERIS PLCequity | $6,188,000 | -10.7% | 70,000 | -17.6% | 3.79% | -6.3% |
| CVS | New | CVS HEALTH CORPequity | $6,099,000 | – | 75,000 | +100.0% | 3.73% | – |
| OBLN | Buy | OBALON THERAPEUTICS INCequity | $5,218,000 | -0.3% | 547,536 | +3.7% | 3.20% | +4.6% |
| CRME | Sell | CARDIOME PHARMA CORPequity | $3,728,000 | -54.2% | 1,750,000 | -2.8% | 2.28% | -51.9% |
| XRAY | Sell | DENTSPLY SIRONA INCequity | $2,991,000 | -40.1% | 50,000 | -35.1% | 1.83% | -37.2% |
| LNTH | Sell | LANTHEUS HOLDINGS INCequity | $2,314,000 | -65.9% | 130,000 | -66.2% | 1.42% | -64.3% |
| ATRC | New | ATRICURE INCequity | $2,237,000 | – | 100,000 | +100.0% | 1.37% | – |
| OPHT | Buy | OPHTHOTECH CORPequity | $2,186,000 | +36.6% | 775,000 | +24.0% | 1.34% | +43.3% |
| RCM | Buy | R1 RCM INCequity | $1,577,000 | +68.1% | 425,000 | +70.0% | 0.97% | +76.3% |
| STRM | Sell | STREAMLINE HEALTH SOLUTIONSequity | $1,539,000 | +26.4% | 1,046,666 | -8.0% | 0.94% | +32.5% |
| EVH | New | EVOLENT HEALTH INC - Aequity | $1,335,000 | – | 75,000 | +100.0% | 0.82% | – |
| SIEN | New | SIENTRA INCequity | $924,000 | – | 60,000 | +100.0% | 0.57% | – |
| New | ESRX US 01/19/18 C60call | $510,000 | – | 1,000 | +100.0% | 0.31% | – | |
| New | HCA US 01/19/18 C80call | $454,000 | – | 1,121 | +100.0% | 0.28% | – | |
| New | HSIC US 01/19/18 P87.5put | $286,000 | – | 400 | +100.0% | 0.18% | – | |
| New | SYK US 11/17/17 P145put | $193,000 | – | 350 | +100.0% | 0.12% | – | |
| Buy | IWM US 11/17/17 P140put | $178,000 | -74.2% | 4,500 | +125.0% | 0.11% | -73.0% | |
| SPY US 10/20/17 P240put | $96,000 | -70.6% | 4,000 | 0.0% | 0.06% | -68.9% | ||
| New | SHPG US 01/19/18 C185call | $94,000 | – | 750 | +100.0% | 0.06% | – | |
| New | BAX US 10/20/17 P62.5put | $18,000 | – | 250 | +100.0% | 0.01% | – | |
| New | ALR US 10/20/17 P50put | $15,000 | – | 1,000 | +100.0% | 0.01% | – | |
| Exit | PATTERSON COMPANIES INC US 07/21/17 P44put | $0 | – | -300 | -100.0% | -0.00% | – | |
| Exit | QUEST DIAGNOSTICS INC US 07/21/17 P110put | $0 | – | -376 | -100.0% | -0.02% | – | |
| Exit | BOSTON SCIENTIFIC CORP US 07/21/17 P28put | $0 | – | -886 | -100.0% | -0.03% | – | |
| Exit | SPECTRANETICS CORP US 10/20/17 C40call | $0 | – | -7,752 | -100.0% | -0.05% | – | |
| Exit | BROOKDALE SENIOR LIVING INC US 07/21/17 C16call | $0 | – | -2,000 | -100.0% | -0.06% | – | |
| Exit | COCA COLA CO US 08/18/17 P46put | $0 | – | -1,000 | -100.0% | -0.08% | – | |
| ALKS | Exit | ALKERMES PLCequity | $0 | – | -30,000 | -100.0% | -1.02% | – |
| SCI | Exit | SERVICE CORP INTERNATIONALequity | $0 | – | -55,000 | -100.0% | -1.07% | – |
| NXTM | Exit | NXSTAGE MEDICAL INCequity | $0 | – | -127,500 | -100.0% | -1.87% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INCequity | $0 | – | -50,000 | -100.0% | -2.29% | – |
| HCA | Exit | HCA HEALTHCARE INCequity | $0 | – | -50,000 | -100.0% | -2.54% | – |
| BKD | Exit | BROOKDALE SENIOR LIVING INCequity | $0 | – | -325,000 | -100.0% | -2.79% | – |
| TVTY | Exit | TIVITY HEALTH INCequity | $0 | – | -155,215 | -100.0% | -3.61% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLCequity | $0 | – | -55,000 | -100.0% | -4.99% | – |
| SPNC | Exit | SPECTRANETICS CORPequity | $0 | – | -265,000 | -100.0% | -5.94% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERADIGM ORD | 32 | Q3 2023 | 13.9% |
| STREAMLINE HEALTH SOLUTIONS ORD | 30 | Q3 2023 | 4.0% |
| ATRICURE ORD | 29 | Q3 2023 | 7.6% |
| PACIRA PHARMACEUTICALS INC | 27 | Q1 2023 | 12.1% |
| LANTHEUS HOLDINGS ORD | 25 | Q4 2022 | 9.6% |
| MEDTRONIC PLC | 21 | Q1 2022 | 12.7% |
| RIGEL PHARMACEUTICALS ORD | 21 | Q2 2023 | 8.0% |
| BIO RAD LABORATORIES CL A ORD | 19 | Q2 2023 | 10.0% |
| HOLOGIC INC | 17 | Q1 2022 | 6.5% |
| SPY US 10/21/16 P210 | 17 | Q3 2023 | 41.5% |
View Tamarack Advisers, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTIONS INC. | June 22, 2023 | 5,514,515 | 9.4% |
| IVERIC bio, Inc. | February 16, 2021 | 850,000 | 0.1% |
| Correvio Pharma Corp. | February 14, 2020 | 2,500,000 | 4.9% |
| OBALON THERAPEUTICS INC | February 14, 2020 | ? | ? |
| Correvio Pharma Corp. | February 15, 2019 | ? | ? |
| Corium International, Inc. | February 15, 2017 | 737,242 | 3.3% |
| ENDOLOGIX INC /DE/Sold out | February 15, 2017 | 0 | 0.0% |
| Imprivata IncSold out | February 15, 2017 | 0 | 0.0% |
View Tamarack Advisers, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-08-10 |
| SC 13D/A | 2023-06-22 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-13 |
| SC 13D/A | 2022-12-01 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-11 |
View Tamarack Advisers, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.